2019 Medicinal Chemistry Reviews
New Progress in Protease-Activated Receptor 1 and 4 (Par-1 and Par-4) Antagonists as Antiplatelet Therapy for Treatment Cardiovascular Disease.
Xiaojun Zhang
Ref. n°: REV2019-ch3
You must be connected to be able to download the pdf file of this chapter.